Jingxian Ding
Impact in
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 4
- Cancer Cells and Metastasis 2
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Yonghong Guo (6 shared papers)Jiong Wu (3 shared papers)Wei Jin (1 shared paper)Canming Chen (1 shared paper)Zhi‐Ming Shao (1 shared paper)Yali Cao (6 shared papers)Li Zhang (1 shared paper)Hui Jiang (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)OncoTargets and Therapy (2 papers)International Journal of Oncology (1 paper)Medicine (1 paper)Oncology Reviews (1 paper)
- Partner nations
- China
In The Last Decade
Jingxian Ding
12 papers receiving 316 citations
Peers
Comparison fields: 5 of 63
- Drug Discovery 1
- Oncology 113
- Biomaterials 57
- Immunology 77
- Pharmaceutical Science 21
Countries citing papers authored by Jingxian Ding
This map shows the geographic impact of Jingxian Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxian Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxian Ding more than expected).
Fields of papers citing papers by Jingxian Ding
This network shows the impact of papers produced by Jingxian Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxian Ding. The network helps show where Jingxian Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingxian Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 97 | |
| 2 | 2022 | 91 | |
| 3 | 2009 | 44 | |
| 4 | 2016 | 35 | |
| 5 | 2020 | 14 | |
| 6 | 2018 | 13 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 5 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2016 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2024 | 0 |
About Jingxian Ding
Jingxian Ding is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 13 papers that have together received 318 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Cancer Cells and Metastasis (2 papers), Immune cells in cancer (2 papers), Estrogen and related hormone effects (1 paper), Inflammatory mediators and NSAID effects (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Blood groups and transfusion (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Oncology (113 citations), Biomaterials (57 citations), Immunology (77 citations) and Pharmaceutical Science (21 citations). Jingxian Ding has collaborated with scholars based in China. Frequent co-authors include Yonghong Guo, Jiong Wu, Wei Jin, Canming Chen, Zhi‐Ming Shao, Yali Cao, Li Zhang, Hui Jiang, Yaohui Wang and Juan Ma. Their work appears in journals such as Frontiers in Oncology, OncoTargets and Therapy, International Journal of Oncology, Medicine and Oncology Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.